{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:24:20Z","timestamp":1789133060523,"version":"build-2803163510"},"reference-count":45,"publisher":"International Society of Global Health","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Glob Health"],"DOI":"10.7189\/jogh.13.04004","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T13:04:40Z","timestamp":1674133480000},"source":"Crossref","is-referenced-by-count":5,"title":["Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia"],"prefix":"10.7189","volume":"13","author":[{"given":"Nora","family":"Schmit","sequence":"first","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevanthi","family":"Nayagam","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"},{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Lemoine","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibril","family":"Ndow","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"},{"name":"Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shimakawa","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019\u00c9pid\u00e9miologie des Maladies \u00c9mergentes, Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Thursz","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B","family":"Hallett","sequence":"additional","affiliation":[{"name":"MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4223","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"key-10.7189\/jogh.13.04004-202301191331-R1","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study.","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.","volume":"3","author":"Polaris Observatory Collaborators","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R3","unstructured":"World Health Organization. Guidelines on Hepatitis B and C testing. Geneva: World Health Organization, 2017."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jhep.2018.05.024","article-title":"Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.","volume":"69","author":"Shimakawa","year":"2018","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R6","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1016\/S2214-109X(16)30130-9","article-title":"Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.","volume":"4","author":"Lemoine","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2468-1253(20)30307-1","article-title":"Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.","volume":"6","author":"Tan","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R8","unstructured":"World Health Organization. Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection. Geneva: World Health Organization, 2015."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R9","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1016\/S2214-109X(16)30101-2","article-title":"Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis.","volume":"4","author":"Nayagam","year":"2016","journal-title":"Lancet Glob Health"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R10","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jval.2020.06.015","article-title":"Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income.","volume":"23","author":"Tordrup","year":"2020","journal-title":"Value Health"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/heapol\/czy018","article-title":"The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up.","volume":"33","author":"Hecht","year":"2018","journal-title":"Health Policy Plan"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Clinical Practice Guidelines on the management of hepatitis B virus infection.","volume":"67","author":"European Association for the Study of the Liver","year":"2017","journal-title":"J Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3851\/IMP1621","article-title":"The natural history of chronic HBV infection and geographical differences.","volume":"15","author":"Liaw","year":"2010","journal-title":"Antivir Ther"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/(SICI)1097-0258(19961030)15:20<2215::AID-SIM369>3.0.CO;2-2","article-title":"The transmission dynamics and control of hepatitis B virus in The Gambia.","volume":"15","author":"Edmunds","year":"1996","journal-title":"Stat Med"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state.","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc Biol Sci"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R16","unstructured":"World Health Organization. WHO\/UNICEF Estimates of National Immunization Coverage. 2019. Available: https:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/wucoveragecountrylist.html. Accessed: 7 December 2019."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/infdis\/jiy391","article-title":"Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study.","volume":"219","author":"Nguyen","year":"2019","journal-title":"J Infect Dis"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R18","doi-asserted-by":"publisher","first-page":"100368","DOI":"10.1016\/j.epidem.2019.100368","article-title":"Approximate Bayesian Computation for infectious disease modelling.","volume":"29","author":"Minter","year":"2019","journal-title":"Epidemics"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1098\/rsif.2008.0172","article-title":"Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems.","volume":"6","author":"Toni","year":"2009","journal-title":"J R Soc Interface"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R20","unstructured":"R Core Team. R: A language and environment for statistical computing. 2020. Available: https:\/\/www.R-project.org\/. Accessed: 31 October 2020."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R21","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1016\/j.vaccine.2016.05.017","article-title":"Barriers to timely administration of birth dose vaccines in The Gambia, West Africa.","volume":"34","author":"Miyahara","year":"2016","journal-title":"Vaccine"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R22","unstructured":"World Health Organization. WHO Global Hepatitis Report. Geneva: World Health Organization, 2017."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R23","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Disability Weights. 2018. Available: http:\/\/ghdx.healthdata.org\/record\/ihme-data\/gbd-2017-disability-weights. Accessed: 4 October 2019."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12962-020-00219-7","article-title":"Introduction of birth dose of hepatitis B virus vaccine to the immunization program in Ethiopia: an economic evaluation.","volume":"18","author":"Memirie","year":"2020","journal-title":"Cost Eff Resour Alloc"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R25","doi-asserted-by":"publisher","first-page":"e000964","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data.","volume":"3","author":"Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2307\/1403510","article-title":"Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example.","volume":"62","author":"Blower","year":"1994","journal-title":"Int Stat Rev"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2334-14-7","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12879-019-3883-9","article-title":"Hepatitis B virus sero-prevalence amongst pregnant women in the Gambia.","volume":"19","author":"Bittaye","year":"2019","journal-title":"BMC Infect Dis"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R29","unstructured":"Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pi\u00f1eros M, et al. Global Cancer Observatory: Cancer Today. 2018. Available: https:\/\/gco.iarc.fr\/. Accessed: 6 May 2019."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R30","unstructured":"World Health Organization. Global and Country Estimates of immunization coverage and chronic HBV infection. 2016. Available: http:\/\/situatedlaboratories.net\/who-hepB-dashboard\/src\/#public-health-strategies. Accessed: 15 July 2021."},{"key":"key-10.7189\/jogh.13.04004-202301191331-R31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.26934","article-title":"Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.","volume":"60","author":"Toy","year":"2014","journal-title":"Hepatology"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/liv.13006","article-title":"The prognosis and management of inactive HBV carriers.","volume":"36","author":"Invernizzi","year":"2016","journal-title":"Liver Int"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1365-2893.2007.00957.x","article-title":"Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.","volume":"15","author":"Papatheodoridis","year":"2008","journal-title":"J Viral Hepat"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jinf.2014.02.018","article-title":"The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon.","volume":"69","author":"Boglione","year":"2014","journal-title":"J Infect"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R35","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1053\/j.gastro.2009.01.011","article-title":"Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.","volume":"136","author":"Kumar","year":"2009","journal-title":"Gastroenterology"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/hep.26041","article-title":"Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.","volume":"57","author":"Tseng","year":"2013","journal-title":"Hepatology"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R37","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s10620-015-3982-4","article-title":"Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.","volume":"61","author":"Uribe","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/qjmed\/hcv118","article-title":"PROLIFICA: a story of West African clinical and research collaborations to target hepatitis B-related hepatocellular carcinoma in West Africa.","volume":"109","author":"Howell","year":"2016","journal-title":"QJM"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2468-1253(16)30161-3","article-title":"Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.","volume":"2","author":"Yang","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12916-014-0145-y","article-title":"Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis.","volume":"12","author":"Mokdad","year":"2014","journal-title":"BMC Med"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R41","doi-asserted-by":"publisher","first-page":"e0227041","DOI":"10.1371\/journal.pone.0227041","article-title":"Eligibility for hepatitis B antiviral therapy among adults in the general population in Zambia.","volume":"15","author":"Vinikoor","year":"2020","journal-title":"PLoS One"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12879-017-2549-8","article-title":"Early experiences from one of the first treatment programs for chronic hepatitis B in sub-Saharan Africa.","volume":"17","author":"Aberra","year":"2017","journal-title":"BMC Infect Dis"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.11604\/pamj.supp.2017.27.3.11981","article-title":"The status of hepatitis B control in the African region.","volume":"27","author":"Breakwell","year":"2017","journal-title":"Pan Afr Med J"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R44","doi-asserted-by":"publisher","first-page":"100533","DOI":"10.1016\/j.jhepr.2022.100533","article-title":"HBV continuum of care using community- and hospital-based screening interventions in Senegal: Results from the PROLIFICA programme.","volume":"4","author":"Sow","year":"2022","journal-title":"JHEP Rep"},{"key":"key-10.7189\/jogh.13.04004-202301191331-R45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jhep.2020.09.013","article-title":"A global investment framework for the elimination of hepatitis B.","volume":"74","author":"Howell","year":"2021","journal-title":"J Hepatol"}],"container-title":["Journal of Global Health"],"original-title":[],"link":[{"URL":"https:\/\/jogh.org\/2023\/jogh-13-04004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T13:04:49Z","timestamp":1674133489000},"score":1,"resource":{"primary":{"URL":"https:\/\/jogh.org\/2023\/jogh-13-04004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7189\/jogh.13.04004","relation":{},"ISSN":["2047-2978","2047-2986"],"issn-type":[{"value":"2047-2978","type":"print"},{"value":"2047-2986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"article-number":"04004"}}